Bioclinica Acquires MDDX Research & Informatics
Bioclinica® announced it has acquired Silicon Valley-based MDDX Research & Informatics, adding advanced cloud research image management and submission technologies to its extensive suite of eHealth solutions. This new acquisition will become the backbone of Bioclinica's SMART solution and will advance the image submission process for clinical research sites.
Read the full release here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Rybrevant Plus Lazcluze Shows Over One-Year Survival Boost in EGFR-Mutated NSCLC Patients
January 7th 2025Results from the Phase III MARIPOSA trial demonstrated the combination of Rybrevant (amivantamab-vmjw) and Lazcluze (lazertinib) significantly improves overall survival compared to the current standard of care, Tagrisso (osimertinib), for patients with EGFR-mutated advanced or metastatic non-small cell lung cancer.
